Literature DB >> 10396379

Limited argon laser peripheral iridoplasty as immediate treatment for an acute attack of primary angle closure glaucoma: a preliminary study.

J S Lai1, C C Tham, D S Lam.   

Abstract

PURPOSE: To study the efficacy and safety of limited (180 degrees) argon laser peripheral iridoplasty (ALPI) as a first-line treatment for acute primary angle closure glaucoma (PACG) without the use of systemic anti-glaucomatous medications.
METHODS: Ten consecutive patients with PACG were recruited into the study. Each patient received topical pilocarpine (4%) and timolol (0.5%), and immediate limited ALPI as primary treatment. The intraocular pressures at 15, 30 and 60 min after ALPI were documented by Goldmann applanation tonometry.
RESULTS: The mean intraocular pressure (IOP) of this group of patients was reduced from 57.9 +/- 10.6 mmHg to 39.0 +/- 10.9 mmHg at 15 min, 28.3 +/- 9.1 mmHg at 30 min and 20.4 +/- 9.0 mmHg at 60 min after ALPI. No complications were encountered. In 8 of the 10 patients the corneal oedema cleared 1 h after ALPI. In the remaining 2 patients the corneal oedema cleared 2 h after ALPI.
CONCLUSION: Immediate limited ALPI, without adjunctive systemic anti-glaucomatous medications, appeared to be effective and safe in controlling the IOP in treating acute PACG with a duration of attack < or = 48 h. It may be as effective as 360 degrees ALPI, and therefore has a role in those patients in whom 360 degrees treatment is not possible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396379     DOI: 10.1038/eye.1999.5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  7 in total

1.  Controlling the temperature of bones using pulsed CO2 lasers: observations and mathematical modeling.

Authors:  Luc Lévesque; Jean-Marc Noël; Calum Scott
Journal:  Biomed Opt Express       Date:  2015-11-09       Impact factor: 3.732

Review 2.  Laser peripheral iridoplasty for angle-closure.

Authors:  Wai Siene Ng; Ghee Soon Ang; Augusto Azuara-Blanco
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

3.  Efficacy and safety of intravenous injection of lidocaine in the treatment of acute primary angle-closure glaucoma: a pilot study.

Authors:  Xiuming Jin; Anquan Xue; Yune Zhao; Qin Qin; Xiang-Da Eric Dong; Jia Qu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-17       Impact factor: 3.117

4.  Primary acute angle closure: long-term clinical outcomes over a 10-year period in the Chinese population.

Authors:  Jacky W Y Lee; Billy K T Wong; Doris W F Yick; Ian Y H Wong; Can Y F Yuen; Jimmy S M Lai
Journal:  Int Ophthalmol       Date:  2013-06-04       Impact factor: 2.031

Review 5.  Acute primary angle closure-treatment strategies, evidences and economical considerations.

Authors:  Poemen P Chan; Jason C Pang; Clement C Tham
Journal:  Eye (Lond)       Date:  2018-11-22       Impact factor: 3.775

Review 6.  Efficacy and Safety of Argon Laser Peripheral Iridoplasty and Systemic Medical Therapy in Asian Patients with Acute Primary Angle Closure: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Wenting Cai; Qiyang Lou; Jiaqi Fan; Donghui Yu; Tianyi Shen; Jing Yu
Journal:  J Ophthalmol       Date:  2019-05-02       Impact factor: 1.909

7.  Argon laser peripheral iridoplasty versus systemic intraocular pressure-lowering medications as immediate management for acute phacomorphic angle closure.

Authors:  Jacky Wy Lee; Jimmy Sm Lai; Doris Wf Yick; Can Yf Yuen
Journal:  Clin Ophthalmol       Date:  2013-01-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.